Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Acquisition

28 Jul 2015 10:44

RNS Number : 2804U
Compagnie de Saint-Gobain
28 July 2015
 



 

 

 

 

July 28, 2015

 

Saint-Gobain strengthens its presence in Indonesia

 

 

 

Saint-Gobain is strengthening its presence in Indonesia by increasing its interest from 51% to 100% in PT Cipta Mortar Utama, which specializes in plastering mortars, masonry mortars, tile fixing and facade renders. The company is Indonesia's leading manufacturer of industrial mortars with estimated sales of over €50 million in 2015.

 

This acquisition bolsters Saint-Gobain's position in Indonesia, where it is also present in abrasives, plastics and plasterboard, and is a perfect fit with the Group's strategy of developing on fast-growing markets.

 

 

ABOUT SAINT-GOBAIN

In 2015, Saint-Gobain is celebrating its 350th anniversary, 350 reasons to believe in the future. Backed by its experience and its capacity to continuously innovate, Saint-Gobain, the world leader in the habitat and construction market, designs, manufactures and distributes high-performance and building materials providing innovative solutions to the challenges of growth, energy efficiency and environmental protection. With 2014 sales of €41 billion, Saint-Gobain operates in 64 countries and has over 180,000 employees. For more information about Saint-Gobain, visit www.saint-gobain.com, the twitter account @saintgobain, or the Saint-Gobain Shareholder app for tablets and smartphones.

 

 

 

Analyst/Investor relations

 

Press relations

 

Gaetano Terrasini

Vivien Dardel

Marine Huet

 

+33 1 47 62 32 52

+33 1 47 62 44 29

+33 1 47 62 30 93

 

 

Sophie Chevallon Susanne Trabitzsch

 

+33 1 47 62 30 48

+33 1 47 62 43 25

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCRPMLTMBITMMA
Date   Source Headline
17th Jan 20135:31 pmRNSNew facility
17th Jan 20135:27 pmRNSDisposal
14th Jan 20137:00 amRNSDisposal
7th Dec 20125:34 pmRNSCredit facility
30th Oct 20124:58 pmRNSNew plant
25th Oct 20125:48 pmRNS1st Quarter Results
16th Oct 20125:56 pmRNSAgreement-Memorandum in solar energy
8th Oct 20126:09 pmRNSFinal Terms
8th Oct 20126:05 pmRNSFinal Terms
8th Oct 20126:05 pmRNSFinal Terms
8th Oct 20126:03 pmRNSFinal Terms
26th Sep 20125:19 pmRNSIssue of Debt
20th Sep 20125:11 pmRNSAcquisition
19th Sep 20122:26 pmRNSMTN Programme Base Prospectus
14th Aug 20123:00 pmRNSMerger Update
2nd Aug 20123:22 pmRNSHalf Yearly Report
27th Jul 20127:00 amRNSHalf Yearly Report
27th Jun 20126:08 pmRNSPublication of Final Terms
27th Jun 20126:07 pmRNSFinal Terms
22nd Jun 20123:00 pmRNSMerger Update
20th Jun 201211:00 amRNSMerger Update
14th Jun 20124:51 pmRNSFinal Terms
8th Jun 20127:59 amRNSAcquisition
8th Jun 20127:00 amRNSAGM Statement
6th Jun 20127:00 amRNSFinal Terms
1st Jun 20125:17 pmRNSCancellation of shares
31st May 20125:29 pmRNSBonds Issue
16th May 20122:48 pmRNSFinal Terms
9th May 20129:52 amRNSAcquisition
3rd May 20124:50 pmRNS1st Quarter Results
30th Mar 20129:16 amRNSDisposal
27th Mar 20124:02 pmRNSPublication of Final Terms
14th Mar 20124:51 pmRNSIssue of Debt
5th Mar 20128:48 amRNSPublication of Prospectus
2nd Mar 201210:01 amRNSFY 2011 Consolidated Financial Statements
19th Jan 20128:39 amRNSFinal Terms EUR100M 4,5% Notes Tranche 3
19th Jan 20128:38 amRNSFinal Terms 4.5% Bonds Tranche4
18th Jan 20123:17 pmRNSFinal Terms of 2019 MTN Programme
14th Dec 20114:53 pmRNSAcquisition
30th Nov 20114:49 pmRNSAcquisition
25th Oct 20115:10 pmRNSThird Quarter Sales Results
30th Sep 20117:00 amRNSFinal Terms
30th Sep 20117:00 amRNSFinal terms
21st Sep 20115:04 pmRNSIssue of Debt
31st Aug 20114:54 pmRNSNew plant
18th Aug 201111:04 amRNSSupplement n°1 to MTN Prospectus
5th Aug 20117:00 amRNSH1-2001 Financial Report, incl. statements
28th Jul 20115:40 pmRNSHalf Yearly Report
27th Jul 20114:59 pmRNSAcquisition
20th Jul 20117:56 amRNSDevelopment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.